跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
INFANTS' IBUPROFEN ORAL SUSPENSION - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
INFANTS' IBUPROFEN ORAL SUSPENSION
Authorized
STANDARD
INFANTS' IBUPROFEN ORAL SUSPENSION
Taro Pharmaceuticals Inc
🇨🇦 Health Canada
Approval Date
Aug 7, 2026
Approval ID
f8e6990b376a39f1
Company
Taro Pharmaceuticals Inc
Type
Standard
Approval Details
Approval Id
f8e6990b376a39f1
Drug Approval Canada Name
INFANTS' IBUPROFEN ORAL SUSPENSION
Product Name
INFANTS' IBUPROFEN ORAL SUSPENSION
Status
Approved
Status Date
2026-06-05
Drug Class
Human
Dosage Form
Drops
Route Of Administration
Oral
Schedule
NON-PRESCRIPTION DRUGS
Atc Original
M01AE01 IBUPROFEN
Aig Number
0108883007
Company Name
Taro Pharmaceuticals Inc
Company Address
130 East Drive Brampton Ontario Canada L6T 1C1
Company Detail Path
/organization/taro-pharmaceuticals-inc
Company Information
Pharmaceutical Company Name
Taro Pharmaceuticals Inc
Country Name
Canada
Province Name
Ontario
City Name
brampton,ontario,country_ca
Address
130 East Dr
Active Ingredients
IBUPROFEN
40 MG / ML
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Aug 7, 2026
Approval ID
f8e6990b376a39f1
Type
Standard
Back to Health Canada Approvals